跳至主要内容
临床试验/NCT00212147
NCT00212147已完成不适用

Subtle Disturbances of Cobalamin Status

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2 个研究点 分布在 1 个国家目标入组 444 人开始时间: 2003年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
444
试验地点
2
主要终点
neuropsychologic performance changes

研究概览

简要总结

Low cobalamin (vitamin B12) levels are frequent in the elderly. Most often they reflect a mild metabolic abnormality without clinical symptoms (subclinical cobalamin deficiency). It is unclear if these elderly people require medical intervention, unlike that small minority with clinical symptoms which can progress and create severe blood or nervous system problems. The study aims to determine if nitrous oxide (N2O), a common anesthetic agent, worsens cobalamin status in elderly patients with unrecognized subclinical cobalamin deficiency. The reason for concern is that N2O inactivates cobalamin and can aggravate the clinical picture of patients who already have clinical manifestations of cobalamin deficiency. The elderly are known to have an increased risk of developing mental changes after surgery and it may be that sometimes these result from aggravation of subclinical cobalamin deficiency.

The study recruits people over the age of 60 years who are undergoing clinically indicated elective surgery requiring general anesthesia for more than 1 hour. Patients meeting exclusion and inclusion criteria are randomized to receive either a standard anesthetic regimen that includes N2O or a nearly identical one without N2O. Before surgery and 2 weeks and 4 weeks after surgery, each patient undergoes (1) a broad battery of tests of cognition and mood and (2) blood tests measuring cobalamin, folate and homocysteine-methionine metabolism to determine whether they have any subtle biochemical impairment of cobalamin status. DNA from blood cells is also tested for the presence of common mutations that affect key enzymes in those metabolic pathways. A brief testing for postoperative delirium is also done 2 hours after surgery.

The patient subgroups' are analyzed for neuropsychologic changes over time, using the preoperative test as the baseline for all comparisons, and associations of those changes with metabolic, genetic, demographic and clinical data.

The primary question is what effect routine N2O exposure has on the latter compared with non-N2O anesthesia in elderly people who either have or do not have subclinical cobalamin deficiency. It will help answer whether or not the combination can help explain the increased risk of cognitive problems after surgery in elderly patients, and by extension whether preoperative cobalamin testing and treatment may be indicated in the elderly. It will also test whether genetic predisposition affects the described problems.

详细描述

Study Design:

  • Double-blind, randomized study of elderly patients scheduled for elective surgery under general anesthesia.
  • Medical, cobalamin-related, and demographic information;
  • Blood tests of cobalamin-related metabolic status and genotyping for 4 relevant mutations;
  • Psychoneurologic evaluation before surgery;
  • Randomization to receive a standard anesthetic regimen with nitrous oxide (N2O) or the same regimen without N2O;
  • Intraoperative and perioperative data are collected;
  • Testing for delirium 2-3 hours after surgery.
  • All preoperative studies are repeated after 2 weeks and 4 weeks.
  • Patients with abnormal cognitive status persisting at 4 weeks receive cobalamin and are retested at 3 months.

Inclusion criteria:

  • Age >60 years;
  • Anticipated duration of general anesthesia >1 hour;
  • Good English comprehension.

Exclusion criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >60 years; elective surgery requiring general anesthesia for an hour or more; English speaker

排除标准

  • Surgery involving CNS, blood supply to head, or cardiovascular system; preexisting dementia, psychosis or stroke; contraindication to any of the planned anesthetic agents; exposure to nitrous oxide in past 6 months; clinical status other than ASA class 1 or 2; bronchospastic or chronic obstructive lung disease; use of cobalamin injections in past 6 months; serum creatinine >1.8 mg.

研究组 & 干预措施

General anesthesia with nitrous oxide

Experimental

干预措施: General anesthesia with nitrous oxide (Drug)

General anesthesia without nitrous oxide

Active Comparator

干预措施: General anesthesia without nitrous oxide (Drug)

结局指标

主要结局

neuropsychologic performance changes

时间窗: 4 weeks

次要结局

  • metabolic changes(4 weeks)

研究者

研究点 (2)

Loading locations...

相似试验

Interaction of Cobalamin Status With Nitrous Oxide... | 临床试验